Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2026-01-13 @ 10:40 AM
Study NCT ID:
NCT00903292
Status:
UNKNOWN
Last Update Posted:
2009-05-18
First Post:
2009-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
Sponsor:
National Cheng-Kung University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2010-12
Completion Date Type:
ESTIMATED
First Submit Date:
2009-05-15
First Submit QC Date:
None
Study First Post Date:
2009-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-05-15
Last Update Post Date:
2009-05-18
Last Update Post Date Type:
ESTIMATED